Ventriculoperitoneal Shunt

A ventriculoperitoneal shunt is a surgically implanted device that diverts excess cerebrospinal fluid from the brain's ventricles to the abdominal cavity, relieving pressure caused by hydrocephalus. Hydrocephalus occurs when cerebrospinal fluid accumulates faster than it can drain naturally, raising pressure inside the skull and potentially causing serious neurological damage if untreated. The shunt provides a continuous, controlled drainage pathway that keeps intracranial pressure within a safe range for as long as the device functions correctly. Because shunts can occasionally block, become infected, or require adjustment as a child grows, lifelong monitoring is an essential part of care.

Ventriculoperitoneal Shunt is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Neurosurgery specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is 2-4 weeks recovery. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes Hospital stay is typically three to seven days, with incision sites monitored closely for infection. Activity is gradually increased over two to four weeks, and lifelong periodic monitoring is needed since shunts may require revision or replacement over time.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

Ventriculoperitoneal Shunt has a documented success rate of 85-90% (shunt revision sometimes needed) at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.